Researchers genotyped Y chromosome markers in almost 100 ancient horse DNA samples spanning 5,000 years.
Teams studying kidney and skin cancers independently implicated SWI/SNF chromatin remodeling mutations in checkpoint blockade immunotherapy response.
Eight draft microbial genomes were generated using DNA in Neanderthal plaque, as part of study aimed at uncovering Neanderthal diet, behavior, and more.
Response to a low toxicity drug called decitabine was most pronounced in acute myeloid leukemia and myelodysplastic syndrome cases with TP53 mutations.
A year after launching the test in the US, the company is making it available in more than 100 countries, partnering with distributors in Israel, Turkey, and Finland.
The Belgian company is also developing new tests and applications with its Multiplex Amplification of Specific Targets for Resequencing technology.
Two separate studies concluded that in most SEO cancer cases what they are seeing are two separate early-stage tumors, instead of late-stage cancer.
Galil Genetic Analysis recently began offering its OncoGenetics RDMGGA 1.0 Re-sequencing Chip as a service to its customers in Israel, according to the company's CEO.
Genomics service provider MoGene will use Fluidigm's Access Array sample preparation platform for its targeted resequencing customers, the companies said today.
By Ben Butkus
The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.
A small study finds differences between three genomic prostate cancer tests, Medscape reports.
In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.
A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.